1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Επιστημών Υγείας
  4. Τμήμα Ιατρικής
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/18437
Full metadata record
DC FieldValueLanguage
dc.contributor.authorEconomopoulos, T.en
dc.contributor.authorStathakis, N.en
dc.contributor.authorAlexopoulos, C.en
dc.contributor.authorPavlidis, N.en
dc.contributor.authorConstantinidou, M.en
dc.contributor.authorBriassoulis, E.en
dc.contributor.authorPapageorgiou, E.en
dc.contributor.authorDervenoulas, J.en
dc.contributor.authorPappa, V.en
dc.contributor.authorVaslamatzis, M.en
dc.contributor.authoret al.,en
dc.date.accessioned2015-11-24T18:52:47Z-
dc.date.available2015-11-24T18:52:47Z-
dc.identifier.issn0390-6078-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/18437-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectAgeden
dc.subjectAged, 80 and overen
dc.subjectFemaleen
dc.subjectFollow-Up Studiesen
dc.subjectGreeceen
dc.subjectHodgkin Disease/pathology/*therapyen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectNeoplasms, Second Primary/*etiologyen
dc.titleSecond malignancies following treatment for Hodgkin's disease: a Greek experienceen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/7926979-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate1994-
heal.abstractThe risk and the type of second malignancies (SM) developing in 217 treated Hodgkin's disease (HD) patients were studied. The median age of the patients was 35 years (range 14-83) and the M/F ratio 1.8. Treatment consisted of radiotherapy alone (24 patients, 11%), chemotherapy alone (96 patients, 44.3%), or a combination of both modalities (43 patients, 19.8%), while 54 patients (24.9%) received salvage treatment. The median follow-up time was 67 months (range 12-224). Ten patients developed a SM with a 5-year and 10-year actuarial risk of 3.3% and 5.4%, respectively. There were 3 cases of ANLL and MDS (actuarial risk of 2.4% at 6 years), 1 case of non-Hodgkin's lymphoma and 6 cases of solid tumors (actuarial risk of 2.4% at 6 years). The risk of developing SM was higher in males and older patients (> 40 years). SM represent a serious late side effect of successful treatment for HD. The possibility of developing a SM must be taken into consideration in the initial treatment of the disease.en
heal.journalNameHaematologicaen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Show simple item record
Files in This Item:
File Description SizeFormat 
Pavlidis-1994-second malignancies following.pdf118.3 kBAdobe PDFView/Open
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons